Fluoxetine Therapeutic Effects With Duloxetine in patients with IBS with constipatio
Phase 3
- Conditions
- Irritable bowel syndrome is a type of constipation.Irritable bowel syndrome
- Registration Number
- IRCT20171115037478N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
new cases of irritable bowel syndrome
aged 18-45
constipation predominant symptoms
consistent with the criteria Rome2 criteria
Exclusion Criteria
patients with night diarrhea
patients with weight loss
patients with history of GI bleeding
patients that use alcohol, drugs and opiums.
patients with psychological diseases
patients with CNS disorders
patients with kidney or liver failure
cardica patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of illness in irritable bowel syndrome, constipation type. Timepoint: At the beginning of the study and two months later. Method of measurement: IBS-SSS(IBS-(Severity scoring system).
- Secondary Outcome Measures
Name Time Method